| |
| |
|
| Insider
Information: |
Wade Jeffrey L |
| Relationship: |
President and CFO |
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
324,214 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$573,859 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
324,214 |
|
|
| Total
Value |
$573,859 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 26.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lexicon Pharmaceuticals Inc |
LXRX |
President and CFO |
2024-02-28 |
324,214 |
2009-02-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
34 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Gen. Counsel |
• – – |
2009-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
44,800 |
47,800 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, General Counsel |
• – – |
2010-02-12 |
4 |
D |
$1.91 |
$13,970 |
D/D |
(7,314) |
34,562 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Dev and CFO |
• – – |
2011-02-23 |
4 |
D |
$1.81 |
$10,726 |
D/D |
(5,926) |
47,973 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Dev and CFO |
• – – |
2011-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
19,337 |
53,899 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Dev and CFO |
• • – |
2013-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,600 |
93,364 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Dev and CFO |
• • – |
2013-01-31 |
4 |
D |
$2.11 |
$21,769 |
D/D |
(10,317) |
83,047 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Dev and CFO |
• • – |
2013-02-28 |
4 |
D |
$1.98 |
$20,713 |
D/D |
(10,461) |
110,836 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Dev and CFO |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,250 |
121,297 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Dev and CFO |
• • – |
2014-02-28 |
4 |
D |
$1.92 |
$31,290 |
D/D |
(16,297) |
149,789 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Dev and CFO |
• • – |
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
55,250 |
166,086 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2015-03-02 |
4 |
D |
$0.94 |
$19,475 |
D/D |
(20,718) |
204,821 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
75,750 |
225,539 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2016-02-29 |
4 |
D |
$9.07 |
$34,602 |
D/D |
(3,815) |
39,393 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2016-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,949 |
43,208 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2017-02-28 |
4 |
D |
$16.45 |
$106,185 |
D/D |
(6,455) |
48,597 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2017-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,659 |
55,052 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2017-11-14 |
4 |
B |
$9.48 |
$18,962 |
D/D |
2,000 |
50,597 |
2.74 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2018-02-28 |
4 |
D |
$8.53 |
$52,314 |
D/D |
(6,133) |
59,492 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2018-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,028 |
65,625 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2019-02-28 |
4 |
D |
$5.51 |
$47,601 |
D/D |
(8,639) |
72,508 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2019-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,655 |
81,147 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2020-02-28 |
4 |
D |
$2.77 |
$44,389 |
D/D |
(16,025) |
98,621 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
42,138 |
114,646 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2020-04-22 |
4 |
D |
$1.96 |
$18,916 |
D/D |
(9,651) |
115,495 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Corp Adm Affairs and CFO |
• • – |
2020-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
26,525 |
125,146 |
0 |
- |
|
34 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
